Ofatumumab versus Teriflunomide in Multiple Sclerosis
Novartis Pharmaceuticals
Stephen L Hauser; Amit Bar-Or; Jeffrey A Cohen; Giancarlo Comi; Jorge Correale; Patricia K Coyle; Anne H Cross; Jerome de Seze; David Leppert; Xavier Montalban; Krzysztof Selmaj; Heinz Wiendl; Cecile Kerloeguen; Roman Willi; Bingbing Li; Algirdas Kakarieka; Davorka Tomic; Alexandra Goodyear; Ratnakar Pingili; Dieter A Häring; Krishnan Ramanathan; Martin Merschhemke; Ludwig Kappos; ASCLEPIOS I and ASCLEPIOS II Trial Groups